Certified by Founder Lodge
Crystalys Therapeutics
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $205,000,000
0 Participating Investments
-
Founded date
2025
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Crystalys is a clinical-stage biopharmaceutical company transforming the treatment of gout. Co-founded by Novo Holdings and Catalys Pacific, Crystalys brings together a world-class team with
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 01 ,2025 | Series A | $205,000,000 |
Lightstone Ventures
Catalys Pacific
KB Investment
Longwood Fund
SR One Capital Management
AN Venture Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
TRIANA Biomedicines | $120,000,000 | (Dec 4, 2025)
Ridley | $6,400,000 | (Dec 4, 2025)
Autolane | $7,400,000 | (Dec 4, 2025)
Juniper Biosciences | $40,000,000 | (Dec 4, 2025)
PineAI | $25,000,000 | (Dec 4, 2025)
